Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

37 year old woman resuscitated after long-term cardiac arrest without neurological damage.

Still today, it is generally believed that within minutes of a heart attack, the brain and other organs are severely damaged. The damage is so severe that with previous therapies successful resuscitation of the patient is very unlikely after a very short time span. Long-term research has shown that the assumed limits can be significantly shifted by a novel set of therapies.

The result is CARL – a new therapeutic approach based mainly on extracorporeal circulation. It is used to draw the patient’s blood from the body, process it and then return it to the patient.

During a CARL Therapy – and this is new – numerous values are measured that provide information about the patient’s condition, so that the composition and temperature of the blood can be adjusted to the patient’s individual needs. This is done by adding certain substances, by a precisely dosed supply of oxygen, and by immediately cooling the entire body to about 34 °C. The corresponding blood values are monitored continuously – and, if necessary, adjusted so that the organism can recover optimally from the consequences of the deficient blood supply (ischemia).

In this way, it was not only possible to resuscitate a relatively young woman and mother in cardiovascular arrest after a time span beyond all positive forecasts. CARL also managed what was previously considered a medical exception: She survived this life-threatening situation without brain damage and and regained her former entire quality of life.